Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease: Incidence, Neurobiological Basis, Management and Prevention

By Antonini Angelo   Cilia Roberto  

Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. : 475-488

Adis International

Access to resources Recommend Favorite

Adverse Haematological Effects of Ticlopidine: Prevention, Recognition and Management

By Love B.B.  

Drug Safety, Vol. 19, Iss. 2, 1998-08 ,pp. : 89-98

Adis International

Access to resources Recommend Favorite

Adverse Drug Reactions in Patients with Phaeochromocytoma: Incidence, Prevention and Management

By Eisenhofer Graeme  

Drug Safety, Vol. 30, Iss. 11, 2007-01 ,pp. : 1031-1062

Adis International

Access to resources Recommend Favorite

Corticosteroid-Induced Adverse Psychiatric Effects: Incidence, Diagnosis and Management

By Patten S.B.  

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 111-122

Adis International

Access to resources Recommend Favorite

Adverse Gastrointestinal Effects of Mycophenolate Mofetil: Aetiology, Incidence and Management

By Behrend M.  

Drug Safety, Vol. 24, Iss. 9, 2001-01 ,pp. : 645-663

Adis International

Access to resources Recommend Favorite